There is strong evidence from randomised cardiovascular outcome trials (CVOTs) that several long-acting GLP-1 RAs (liraglutide, dulaglutide and subcutaneous semaglutide) provide cardiovascular protection to individuals with T2D with pre-existing cardiovascular disease (secondary prevention) or at high risk of CV events, and to a lesser extent those without overt atherosclerotic vascular disease (primary prevention
Weight loss medication of this kind can be especially useful if youve previously struggled to lose weight using conventional methods, like dieting and increasing physical activity
Tirzepatide slows gastric emptying, which can temporarily reduce how quickly your body absorbs the B vitamins and amino acids in Lipo C injections
Diabetologia 67(Suppl
Clinicians must therefore rely on general safety data, pharmacologic principles, and individualized clinical judgment when prescribing semaglutide to these patients
demonstrated that GLP-1RAs, such as semaglutide, confer protective effects in polymicrobial sepsis by activating neuronal GLP-1R